Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-01-30
2007-01-30
Tsang, Cecilia J. (Department: 1654)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
Reexamination Certificate
active
10283549
ABSTRACT:
Compounds of formula (SEQ ID NO:2) and (SEQ ID NO:3), which are useful for treating conditions that arise from or are exacerbated by angiogenesis, are described. Also disclosed are pharmaceutical compositions comprising these compounds, methods of treatment using these compounds, and methods of inhibiting angiogenesis.
REFERENCES:
patent: 5140009 (1992-08-01), Haviv et al.
patent: 99/61476 (1999-12-01), None
patent: 01/38347 (2001-05-01), None
patent: 01/38397 (2001-05-01), None
Flouret, et al., Effects of D-Amino Acid Substituents on Degradation of LHRH Analogues by Proximal Tubule, American Journal of Physiology, Mar. 1987, vol. 272, Issue 3, Pt. 1, pp. E320-326.
Bagley, et al., Endothelial Precursor Cells As a Model of Tumor Endothelium : Characterization and Comparison with Mature Endothelial Cells, Cancer Research, Sep. 15, 2003, vol. 63, pp. 5866-5873.
Harvey Black, Angiogenesis—Promoting and Blocking—Comes into Focus, The Scientist, Apr. 27, 1998, vol. 12, No. 9, pp. 10-14.
Scott Veggeberg, Fighting Cancer with Angiogenesis Inhibitors, The Scientist, May 27, 2002, vol. 16, No. 11, pp. 41-46.
Trisha Gura, Systems for Identifying New Drugs are Often Faulty, Science, Nov. 7, 1997, vol. 278, pp. 1041-1042.
Gerald B. Dermer, Another Anniversary for the War on Cancer, Biotechnology, Mar. 1994, vol. 12, p. 320.
Flouret et al. “Effects of D-amino acid substituents on degradation of LHRH analogoues by proximal tubule.” Am. J. Physiol. 1987, 252, E320-E326.
Yang et al. “Characterization of proteolytic activites of pulmonary alveolar epithelium.” Int. J. Pharm. 2000, 195, 93-101.
Hagedom & Bikfalvi “Target molecules for anti-angiogenic therapy: from basic research to clinical trials.” Crit. Rev. Onc./Hemat., 2000, 34, 89-110.
Bradley Michael F.
Haviv Fortuna
Abbott Laboratories
Bradley Christina M.
Corbin Johanna M.
Steele Gregory W
Tsang Cecilia J.
LandOfFree
Tetra-, penta-, hexa- and heptapeptides having... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tetra-, penta-, hexa- and heptapeptides having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tetra-, penta-, hexa- and heptapeptides having... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3743301